Lansoprazole Patent Expiration
Lansoprazole was first introduced by Takeda Pharmaceuticals Usa Inc
Lansoprazole Patents
Given below is the list of patents protecting Lansoprazole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lansoprazole | US11077055 | Orally disintegrating compositions | Apr 21, 2036 | Dexcel |
| Lansoprazole | US11986554 | Orally disintegrating compositions | Apr 21, 2036 | Dexcel |
| Prevacid | US5464632 | Rapidly disintegratable multiparticular tablet |
Nov 07, 2012
(Expired) | Takeda Pharms Usa |
| Prevacid |
US5464632 (Pediatric) | Rapidly disintegratable multiparticular tablet |
May 07, 2013
(Expired) | Takeda Pharms Usa |
| Prevacid | US6328994 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US6328994 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid | US7399485 | Rapidly Disintegrable solid preparation |
May 26, 2018
(Expired) | Takeda Pharms Usa |
| Prevacid |
US7399485 (Pediatric) | Rapidly Disintegrable solid preparation |
Nov 26, 2018
(Expired) | Takeda Pharms Usa |
| Prevacid | US7431942 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US7431942 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid | US7875292 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US7875292 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid | US9901546 | Orally disintegrable tablets |
May 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid |
US9901546 (Pediatric) | Orally disintegrable tablets |
Nov 17, 2019
(Expired) | Takeda Pharms Usa |
| Prevacid Iv | US7396841 | Injections |
Aug 17, 2021
(Expired) | Takeda Pharms Na |
| Prevacid Iv |
US7396841 (Pediatric) | Injections |
Feb 17, 2022
(Expired) | Takeda Pharms Na |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lansoprazole's patents.
Latest Legal Activities on Lansoprazole's Patents
Given below is the list recent legal activities going on the following patents of Lansoprazole.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation | 03 Aug, 2021 | US11077055 |
| Recordation of Patent Grant Mailed | 03 Aug, 2021 | US11077055 |
| Email Notification | 15 Jul, 2021 | US11077055 |
| Issue Notification Mailed | 14 Jul, 2021 | US11077055 |
| Dispatch to FDC | 28 Jun, 2021 | US11077055 |
| Application Is Considered Ready for Issue | 28 Jun, 2021 | US11077055 |
| Issue Fee Payment Verified | 23 Jun, 2021 | US11077055 |
| Issue Fee Payment Received | 23 Jun, 2021 | US11077055 |
| Electronic Review | 19 Jun, 2021 | US11077055 |
| Email Notification | 18 Jun, 2021 | US11077055 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Lansoprazole Generics
Several generic applications have been filed for Lansoprazole. The first generic version for Lansoprazole was by Mylan Pharmaceuticals Inc and was approved on Nov 10, 2009. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Mar 28, 2023.
Given below is the list of companies who have filed for Lansoprazole generic.
1. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2020 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | May 18, 2020 |
2. NATCO
Natco Pharma Ltd has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | Jan 13, 2016 |
3. LANNETT CO INC
Lannett Co Inc has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 29, 2017 |
4. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Sep 21, 2017 |
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Sep 21, 2017 |
5. ZYDUS HLTHCARE
Zydus Healthcare Usa Llc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Zydus Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 19, 2013 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 19, 2013 |
6. KRKA TOVARNA ZDRAVIL
Krka Tovarna Zdravil Dd Novo Mesto has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Krka Tovarna Zdravil.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 16, 2013 |
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 16, 2013 |
7. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 27, 2018 |
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 27, 2018 |
8. WOCKHARDT
Wockhardt Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Wockhardt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 14, 2012 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 14, 2012 |
9. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Oct 15, 2010 |
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | May 18, 2012 |
10. XIROMED
Xiromed Pharma Espana Sl has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Xiromed.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jul 25, 2016 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jul 25, 2016 |
11. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 23, 2010 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Apr 23, 2010 |
12. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 14, 2016 |
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 14, 2016 |
13. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | May 18, 2012 |
14. NATCO PHARMA LTD
Natco Pharma Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Natco Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 18, 2012 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Dec 18, 2012 |
15. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
16. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 28, 2018 |
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Nov 28, 2018 |
17. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Feb 1, 2021 |
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Feb 1, 2021 |
18. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating, delayed release | Discontinued | ORAL | N/A | Oct 15, 2010 |
| 30MG | tablet, orally disintegrating, delayed release | Discontinued | ORAL | N/A | Oct 15, 2010 |
19. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 28, 2017 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Sep 28, 2017 |
20. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Nov 10, 2009 |
21. INVENTIA
Inventia Healthcare Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Inventia.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 30, 2017 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Aug 30, 2017 |
22. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Mar 28, 2023 |
| 15MG | tablet, orally disintegrating, delayed release | Prescription | ORAL | AB | Mar 28, 2023 |
23. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 13, 2013 |
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Sep 13, 2013 |
24. BRECKENRIDGE
Breckenridge Pharmaceutical Inc has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Breckenridge.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 17, 2018 |
| 30MG | capsule, delayed rel pellets | Discontinued | ORAL | N/A | Oct 17, 2018 |
25. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Lansoprazole. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 18, 2019 |
| 15MG | capsule, delayed rel pellets | Prescription | ORAL | AB | Jan 18, 2019 |
26. PERRIGO R AND D
Perrigo R And D Co has filed for 1 generic for Lansoprazole. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule, delayed rel pellets | Over the counter | ORAL | N/A | May 18, 2012 |